Top Tweets for #aLC

$IBRX therapeutic framing: Platforms like Tri-Ad5 and IL-15 superagonists are classified as therapeutic cancer vaccines + immunotherapy — not traditional prophylactic vaccines. Key distinction: These are given after a cancer diagnosis, not to healthy people to prevent disease. How it works: They train the patient’s own immune system (especially NK cells and CD8+ T cells) to recognize, infiltrate, and destroy existing tumor cells, while building long-term immune memory to help prevent recurrence. Therapeutic cancer vaccine approach.

Prevention matters too. Prevention against metastasis and recurrence. It's known NK cells defend against cancer metastasis. Maintaining an adequate ALC must be a priority immediately upon cancer diagnosis. The answers exist now to help make this possible. https://t.co/SrKAd7MGbM